Volume | 653,815 |
|
|||||
News | - | ||||||
Day High | 1.06 | Low High |
|||||
Day Low | 0.9754 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
FibroGen Inc | FGEN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.04 | 0.9754 | 1.06 | 1.04 | 1.02 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,010 | 653,815 | US$ 1.03 | US$ 674,062 | - | 0.3333 - 19.47 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:21:08 | formt | 500 | US$ 1.02 | USD |
FibroGen Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
102.72M | 98.77M | - | 147.75M | -284.23M | -2.88 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
FibroGen News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FGEN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.16 | 1.26 | 0.90105 | 1.06 | 1,378,356 | -0.14 | -12.07% |
1 Month | 2.35 | 2.3975 | 0.90105 | 1.43 | 1,867,896 | -1.33 | -56.60% |
3 Months | 2.375 | 2.93 | 0.90105 | 1.94 | 2,191,651 | -1.36 | -57.05% |
6 Months | 0.518 | 2.93 | 0.3333 | 1.41 | 2,286,057 | 0.502 | 96.91% |
1 Year | 16.31 | 19.47 | 0.3333 | 2.53 | 2,894,380 | -15.29 | -93.75% |
3 Years | 21.81 | 30.1249 | 0.3333 | 7.65 | 1,619,097 | -20.79 | -95.32% |
5 Years | 47.80 | 57.2088 | 0.3333 | 15.27 | 1,297,232 | -46.78 | -97.87% |
FibroGen Description
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. |